From science to a profitable business.
Biotech Strategy
We help biotech and biopharma companies turn innovation into viable products, with real strategy, regulatory pathways and market execution.
Combined track record
+50
years of experience in biotech and business strategy
FDA · EMA
Products approved by leading global agencies
Regulatory reach
Global presence
3 sedes principales
Spain · Switzerland · Mexico · active international network
The problem is not the science
"The majority of biotech projects never reach the market. Not due to lack of innovation, but due to lack of strategic direction."
THE DIAGNOSTIC
Science - business gap
Regulatory labyrinths
Fragile business models
Non existing Go-to-market
High-level scientific teams without commercial structure or market vision.
Pathways to FDA and EMA that consume years without experienced guidance.
Technical validation without commercial validation or financial planning.
Products ready for market with no clear route to partners, distribution or investment.
Three levers of transformation
What we do
Strategic Diagnostic
Ongoing advisory
Scaling Programme
We assess the commercial potential of your technology with scientific rigour and both regional and international market perspective. We identify opportunities, risks and the optimal roadmap.
Strategic support in critical decisions, active search for partners, investors and alliances. Access to our international biopharma network.
We design a tailored roadmap covering regulatory validation, business model and go-to-market strategy. Proven methodology, real execution.
ENTRY POINT
CORE PROCESS
LONG-TERM PARNER
01
02
03
Real differentiation, not generic consulting
WHY US
FDA·EMA experience
Execution, no reports
Integrated science + business
Direct track record in product approvals. Not regulatory theory, but proven execution.
Proprietary methodologies focused on tangible results. No endless decks or analysis without action.
A unique team combining senior PhD-level science and strategic MBA expertise working in parallel from day one.
I
Active international network
Real connections across global biopharma. Partners, distributors and investors across Europe, the Americas and beyond.
II
III
IV
Founding team
WHO WE ARE
PhD Jorge F. Paniagua Solís
SCIENTIFIC & REGULATORY DIRECTOR
PhD in Biochemistry and Immunology
25+ years in biotech development
FDA-approved products
International consultant in biopharma and WHO
Expert in therapeutic antibodies and technology transfer
Sergio Suárez Toriello, MBA
STRATEGY & BUSINESS DIRECTOR
25+ years in strategy and business development
Specialist in transformation and growth
Proprietary strategic planning methodologies
Results-driven approach, not theory
Proven experience in international scaling
sergio@bbsstrategy.es
jorge@bbsstrategy.es
The process
HOW WE WORK
Diagnostic
Execution
Roadmap
An initial no-cost conversation to assess your project, understand its development stage and determine whether we are the right partner.
Hands-on support across every phase: validation, approval, go-to-market and partner search. We act as part of your team, not external consultants.
In-depth commercial and regulatory analysis. We deliver a concrete strategic plan with milestones, timelines and required resources.
STEP 01
STEP 02
STEP 03
Your science deserves to reach the market
Speak with us. The initial conversation is free and without obligation.
THE FIRST STEP
info@bbsstrategy.es
Contacto
España · Suiza · México